These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 17166384

  • 1. [Efficacy of chemotherapy regimen using ifosphamide and carboplatin on recurrent or refractory neuroblastoma].
    Zhen ZJ, Sun XF, Xia Y, Wang ZH, Ling JY.
    Ai Zheng; 2006 Dec; 25(12):1550-2. PubMed ID: 17166384
    [Abstract] [Full Text] [Related]

  • 2. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
    Zhou SY, Shi YK, He XH, Zhang P, Dong M, Huang DZ, Yang JL, Zhang CG, Liu P, Yang S, Feng FY.
    Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
    [Abstract] [Full Text] [Related]

  • 3. Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma.
    Abali H, Urün Y, Oksüzoğlu B, Budakoğlu B, Yildirim N, Güler T, Ozet G, Zengin N.
    Cancer Invest; 2008 May; 26(4):401-6. PubMed ID: 18443961
    [Abstract] [Full Text] [Related]

  • 4. [MINE regimen for patients with relapsed or chemo-resistant invasive non-Hodgkin's lymphoma].
    Fan Y, Huang ZY, Luo LH, Yu HF.
    Ai Zheng; 2005 Dec; 24(12):1503-6. PubMed ID: 16351801
    [Abstract] [Full Text] [Related]

  • 5. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
    Musolino A, Perrone MA, Michiara M, Delnevo D, Franciosi V, Di Blasio B, Ceci G, Camisa R, Ardizzoni A, Cocconi G.
    Cancer; 2005 May 15; 103(10):2109-17. PubMed ID: 15803492
    [Abstract] [Full Text] [Related]

  • 6. Ifosfamide, carboplatin, and etoposide for neuroblastoma: a high-dose salvage regimen and review of the literature.
    Kushner BH, Modak S, Kramer K, Basu EM, Roberts SS, Cheung NK.
    Cancer; 2013 Feb 01; 119(3):665-71. PubMed ID: 22951749
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of efficacy of treatment for 30 children with neuroblastoma].
    Sun XF, Liu DG, Su YS, Lin TY, Chen XQ, He YJ.
    Ai Zheng; 2003 Dec 01; 22(12):1343-5. PubMed ID: 14693065
    [Abstract] [Full Text] [Related]

  • 8. Topotecan combined with myeloablative doses of thiotepa and carboplatin for neuroblastoma, brain tumors, and other poor-risk solid tumors in children and young adults.
    Kushner BH, Cheung NK, Kramer K, Dunkel IJ, Calleja E, Boulad F.
    Bone Marrow Transplant; 2001 Sep 01; 28(6):551-6. PubMed ID: 11607767
    [Abstract] [Full Text] [Related]

  • 9. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
    Barişta I, Tekuzman G, Yalçin S, Güllü I, Güler N, Ozişik Y, Kars A, Celik I, Türker A, Altundağ K, Zengin N, Uner A, Baltali E, Firat D.
    J Surg Oncol; 2000 Jan 01; 73(1):12-6. PubMed ID: 10649272
    [Abstract] [Full Text] [Related]

  • 10. A phase 2 trial of ifosfamide/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy.
    Sørensen P, Pfeiffer P, Bertelsen K.
    Gynecol Oncol; 1995 Jan 01; 56(1):75-8. PubMed ID: 7821851
    [Abstract] [Full Text] [Related]

  • 11. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Li EX, Zhang YT, Shang JT, Xu Z, Geng Y, Li SM, Shi F, Wu YY.
    Ai Zheng; 2006 Aug 01; 25(8):1048-51. PubMed ID: 16965692
    [Abstract] [Full Text] [Related]

  • 12. [Pilot study of relapsed osteosarcoma and brain tumor with ifosfamide, carboplatin and etoposide (ICE therapy)].
    Hirota T, Takeuchi M, Iwata A, Kitagawa S, Sato T, Konno K, Sawada K, Kobayashi S, Hamaguchi N, Agata H, Katano N, Fujimoto T.
    Gan To Kagaku Ryoho; 1998 Feb 01; 25(3):385-90. PubMed ID: 9492832
    [Abstract] [Full Text] [Related]

  • 13. Refining therapeutic strategies for patients with resistant Wilm's tumor.
    Marina NM, Wilimas JA, Meyer WH, Jones DP, Douglass EC, Pratt CB.
    Am J Pediatr Hematol Oncol; 1994 Nov 01; 16(4):296-300. PubMed ID: 7978044
    [Abstract] [Full Text] [Related]

  • 14. Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation in patients with poor-prognosis solid tumors - Bulgarian experience.
    Avramova B, Jordanova M, Michailov G, Konstantinov D, Christosova I, Bobev D.
    J BUON; 2006 Nov 01; 11(4):433-8. PubMed ID: 17309174
    [Abstract] [Full Text] [Related]

  • 15. Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients--long-term results of a phase II study.
    Baur M, Fazeny-Doerner B, Hudec M, Sevelda P, Salzer H, Dittrich C.
    Cancer Invest; 2006 Feb 01; 24(1):22-7. PubMed ID: 16466988
    [Abstract] [Full Text] [Related]

  • 16. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
    Kim DW, Jo YH, Kim JH, Wu HG, Rhee CS, Lee CH, Kim TY, Heo DS, Bang YJ, Kim NK.
    Cancer; 2004 Nov 15; 101(10):2257-60. PubMed ID: 15484215
    [Abstract] [Full Text] [Related]

  • 17. Serial intense chemotherapy combining topotecan, etoposide, carboplatin and cyclophosphamide (TECC) followed by autologous hematopoietic stem cell support in patients with high risk soft tissue sarcoma (STS).
    Bernbeck B, Bahci S, Meisel R, Troeger A, Schönberger S, Laws HJ, Kramm C, Wessalowski R, Koscielniak E, Dilloo D, Göbel U.
    Klin Padiatr; 2007 Nov 15; 219(6):318-22. PubMed ID: 18050041
    [Abstract] [Full Text] [Related]

  • 18. The use of ifosfamide, carboplatin, and etoposide in children with solid tumors.
    Cairo MS.
    Semin Oncol; 1995 Jun 15; 22(3 Suppl 7):23-7. PubMed ID: 7610395
    [Abstract] [Full Text] [Related]

  • 19. The incidence of hearing impairment after successful treatment of neuroblastoma.
    Simon T, Hero B, Dupuis W, Selle B, Berthold F.
    Klin Padiatr; 2002 Jun 15; 214(4):149-52. PubMed ID: 12165893
    [Abstract] [Full Text] [Related]

  • 20. [Efficacy of DICE (dexamethasone, etoposide, ifosfamide, and cisplatin) regimen on recurrent and refractory non-Hodgkin's lymphoma].
    Bo LJ, Liang AB, Liu B, Chen YH, Wang F, Jin XP.
    Ai Zheng; 2006 Dec 15; 25(12):1553-6. PubMed ID: 17166385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.